High Resolution Immune Profiling Assay Characterizes the Antibody Response to Moderna’s COVID-19 Vaccine
GOLETA, CALIFORNIA, UNITED STATES, March 28, 2024 /EINPresswire.com/ -- In a study published in Frontiers in Immunology, researchers at Moderna Inc. and Serimmune characterized the antibody response profiles to SARS-CoV-2 messenger RNA (mRNA) …